BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 28465354)

  • 1. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30135355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.
    Papi A; Govoni M; Ciavarella C; Spisni E; Orlandi M; Farabegoli F
    Curr Cancer Drug Targets; 2016; 16(4):373-85. PubMed ID: 26278714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
    Sen T; Dutta A; Chatterjee A
    Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.
    Farabegoli F; Govoni M; Ciavarella C; Orlandi M; Papi A
    Biomed Res Int; 2014; 2014():853086. PubMed ID: 25013807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
    Sen T; Chatterjee A
    Eur J Nutr; 2011 Sep; 50(6):465-78. PubMed ID: 21170718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling.
    Cui H; Yuan J; Du X; Wang M; Yue L; Liu J
    Oncol Rep; 2015 Mar; 33(3):1284-90. PubMed ID: 25522911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.
    Sen T; Moulik S; Dutta A; Choudhury PR; Banerji A; Das S; Roy M; Chatterjee A
    Life Sci; 2009 Feb; 84(7-8):194-204. PubMed ID: 19105967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages.
    Wang QM; Wang H; Li YF; Xie ZY; Ma Y; Yan JJ; Gao YF; Wang ZM; Wang LS
    Cell Physiol Biochem; 2016; 39(6):2308-2319. PubMed ID: 27832636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
    Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E
    Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
    Thangapazham RL; Passi N; Maheshwari RK
    Cancer Biol Ther; 2007 Dec; 6(12):1938-43. PubMed ID: 18059161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
    Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH
    J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
    Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
    Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation of MDA-MB-231 can be suppressed by dimeric-epigallocatechin gallate through competitive inhibition of amphiregulin-epidermal growth factor receptor signaling.
    Huang Y; Zhang X; Pang Q; Zhu Q; Liang Q; Zi C; Zhang D; Xiang Z; Wang X; Sheng J
    Anticancer Drugs; 2021 Jun; 32(6):647-656. PubMed ID: 33587351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
    Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
    Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL; Cardelli JA
    Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
    Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.